Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-28

FDA Approved: RAMELTEON — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Granules Pharmaceuticals' generic ramelteon, enabling market entry for the treatment of insomnia characterized b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)